An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
Phase 4
20
about 2.8 years
18–50
Female only
1 site in TX
About this study
Researchers are testing a treatment called brexanolone, given as an injection into a vein, to see if it helps reduce symptoms of PTSD in adult women. The trial will last 1004 days and involve approximately 20 women with PTSD who are not veterans.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Brexanolone Injection [Zulresso]
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
brexanolone
injection
Primary: Change in PTSD Symptom Severity: PTSD Checklist for DSM-5 (PCL-5)
Secondary: Change in Depressive Symptoms: Montgomery-Asberg Depression Rating Scale (MADRS), Change in PTSD Subscale Symptoms: PTSD Checklist for DSM-5 (PCL-5)
Psychiatry / Mental Health